OBJECTIVES The purpose of this study was to determine whether a transcatheter procedure or surgical closure offers a better value proposition for atrial septal defect (ASD) closure.
A trial septal defects (ASD) are a common form of congenital heart disease, accounting for about 10% of all congenital heart defects in children (1) . Secundum type ASDs are the most common variant, constituting for approximately 75% of all ASDs.
Historically, the standard treatment for patients with ASDs has always been surgical closure through a median sternotomy using cardiopulmonary bypass.
This method has been proven to be safe and effective with excellent long-term results (2, 3) . Since the first introduction of an ASD device closure using a double- Heart Association now stress the importance of value assessments as a criterion when developing guidelines (14) . Several small, single-institutional studies have previously reported better value of transcatheter ASD closure when compared with surgery (7) (8) (9) 11, 15) . However, recent data have shown tremendous variability in hospital and procedural costs between individual centers (16) . The only multicentered study that has addressed this issue to date was done in adults and outside of the United States (17) .
We sought to compare the value of transcatheter and surgical ASD closure in children in the United
States by comparing the costs and outcomes of the respective procedures. We hypothesized that a transcatheter option confers a better value when compared with surgery.
METHODS
A retrospective cohort study was conducted using data from the Pediatric Health Information System (PHIS) database; a large, multicenter administrative database (18) . Data such as demographics, diagnoses, procedures, interventions, outcomes and charges for all inpatient encounters are collected from over 40 U.S. pediatric tertiary care hospitals that are members of the Children's Hospital Association. This organization provides a range of services to its member hospitals in efforts to reduce hospital costs, increase revenue, advance competitiveness, and improve the quality of care for children. Data quality is ensured by careful systemic monitoring, including coding consensus meetings bimonthly, coding consistency reviews, and quarterly data quality reports. It has proven itself in the past to be a good platform for outcomes and quality based research.
We included in our analyses all children ages 1 to 17 years that underwent either transcatheter or surgical Ooi et al.
Transcatheter vs. Surgical Closure of ASD in Children J A N U A R Y 1 1 , 2 0 1 6 : 7 9 -8 6 wanted to focus our study on otherwise healthy individuals to avoid skewing our data. We then compared the values of both the procedures, with value in health care being defined as "outcomes relative to costs" (19) . Patient characteristics are summarized in Table 1 . Values are n (%). *Models were adjusted for race, presence of comorbidity, age at surgery, sex, and hospital. The odds ratio (OR) and 95% confidence interval (CI) were determined using transcatheter patients as the reference group.
ASD ¼ atrial septal defect. Values are mean (95% CI). *Mean estimates and 95% confidence intervals (CI) as based on the back-transformed log function. Model for length of stay was adjusted for race, presence of comorbidity, age at surgery, sex, and hospital. Model for charges was adjusted for race, presence of comorbidity, age at surgery, sex, hospital, and length of stay.
Ooi et al. Although several other studies have shown similar results previously, they were mostly small, singleinstitution studies (7) (8) (9) 11, 15) . Our study revealed very large interinstitutional variations in hospital charges for each procedure, with no significant correlation between the costs of transcatheter and Upper and lower error bars indicate 25th and 75th percentiles, respectively. ASD ¼ atrial septal defect.
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surgical ASD closure in each individual hospital.
Therefore it is important to compare costs across several different institutions to draw meaningful comparisons and conclusions of the value between the procedures. The only multicentered study in the literature so far was performed on adults and outside Ooi et al.
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the United States (17) . To the best of our knowledge, our study is the only large multicentered study focused on addressing this issue in the pediatric population in the United States.
The relatively lower cost of transcatheter group likely reflects shorter length of hospitalization and shorter/lack of intensive care unit stays. These lead to a subsequent reduction of pharmacy, respiratory, nursing, radiology, laboratory and transfusion costs (8, 9, 11, 15, 17) . Also, the steep cost of transcatheter devices may have been compensated by the expense of extracorporeal circulation equipment needed for cardiac bypass (7).
Another important element that needs to be considered is the societal burden and cost that is Another limitation to consider is that our procedural cost had to be estimated using cost-to-charge ratios to convert hospital charges to actual cost, so our calculated costs may not be entirely accurate.
However hospital cost-to-charge ratios should affect both transcatheter and surgical cases equally, so the relative costs of the procedures should be the same. WHAT IS NEW? Our study showed that transcatheter ASD closure is as safe and provides better value when compared with surgical ASD closure, at least in the short term.
WHAT IS NEXT? The next step is to evaluate the long-term value of these procedures. Transcatheter vs. Surgical Closure of ASD in Children
